A federal judge in Trenton, N.J., has dismissed a patent infringement suit by Takeda Pharmaceutical Co. against a company seeking to produce a generic version of its Prevacid SoluTab heartburn drug.
The abbreviated new drug application filed with the Food and Drug Administration by Zydus Pharmaceuticals for permission to sell a version of Prevacid does not infringe on Takeda’s patents, U.S. District Judge Joel Pisano ruled on Oct. 16.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
